内静脉阿米奥达龙在预兴奋性心房:一个系统的审查
Zain S Ali1, David L Nguyen2, Abdullah Bhuiyan1
1Faculty of Health Sciences, School of Medicine, Queen's University, Kingston (Z.S.A., A. Bhuiyan, A.M.).
Circulation. Arrhythmia and electrophysiology
|February 25, 2026
概括
静脉注射阿米奥达龙很少与预兴起性心房 (AF) 中的心室动 (VF) 相关,尽管目前的指导方针. 在资源有限的环境中,这种药物可能是一个可行的替代品,而其他治疗方法是不可用的.
科学领域:
- 心脏病学 心脏病学
- 临床药理学 临床药理学
背景情况:
- 目前的指导方针对因心室动 (VF) 风险导致的预兴奋性心房动 (AF) 进行静脉注射阿米奥达龙的禁忌.
- 建议是基于有限的案例报告,与阿米奥达龙在资源有限的地区的全球使用形成鲜明对比.
研究的目的:
- 系统地审查静脉注射阿米奥达龙在患有预激发性AF的患者中的安全性.
- 评估指南推的替代抗不律性药物的现实可用性.
主要方法:
- 对静脉注射amiodarone在预激发AF和辅助通路耐火期的研究进行系统审查.
- 使用β-双项模型对观察性和干预性研究进行了聚合分析.
- 拉丁美洲紧急服务部门关于药物可获得性的跨国调查.
主要成果:
- 包括12项研究 (177名患者);4份病例报告指出VF,但在观察/干预队列的146名患者中没有发生VF.
- 估计VF风险在0.12%至0.68%之间.
- 艾米奥达龙增加了前级有效耐火期;在被调查的中心没有可用的替代药物.
结论:
- 人口层面的证据表明,在预兴奋的AF中,静脉注射阿米奥达龙可能存在罕见的风险.
- 当指导方针推的药物无法获得时,静脉注射阿米奥达龙可能是节奏或节奏控制的合理替代方案.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.7K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.7K
Dysrhythmias VI: Management of Dysrhythmias
544
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
544
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
697
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
697
Disturbances in Heart Rhythm
3.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.3K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
3.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.8K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.0K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.0K


